Malzahn Craig 4
4 · REGENXBIO Inc. · Filed Jan 8, 2026
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Malzahn Craig
Chief Technology Officer
Transactions
- Award
Common Stock
2026-01-06+65,847→ 82,194 total - Award
Stock Options (Right to buy)
2026-01-06+35,402→ 35,402 totalExercise: $14.18Exp: 2036-01-06→ Common Stock (35,402 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer.
- [F2]25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer.